KEGG: mmr:Mmar10_2204
STRING: 394221.Mmar10_2204
Maricaulis maris ATP synthase subunit b 2 (atpF2) is a component of the F-type ATP synthase complex, specifically part of the membrane-embedded F₀ sector. This protein plays a critical role in the structural organization of the ATP synthase complex, connecting the F₀ and F₁ domains and participating in the proton translocation pathway necessary for ATP synthesis. The complete protein consists of 183 amino acids and is encoded by the atpF2 gene (Mmar10_2204 locus) .
Unlike the catalytic subunits, subunit b 2 serves primarily as a structural component that facilitates the mechanical coupling between proton translocation through the membrane and the conformational changes required for ATP synthesis. The protein contributes to maintaining the structural integrity of the complex during rotational catalysis.
For optimal experimental outcomes when working with recombinant Maricaulis maris ATP synthase subunit b 2, researchers should follow these evidence-based handling protocols:
Storage conditions: Store the protein at -20°C for routine use, or at -80°C for extended storage periods. The protein is typically supplied in a Tris-based buffer containing 50% glycerol optimized for stability .
Avoid repeated freeze-thaw cycles: These can significantly compromise protein integrity. Instead, prepare small working aliquots during initial thawing .
Working aliquots can be stored at 4°C for up to one week to minimize degradation from repeated temperature changes .
When designing experiments, consider that the protein's activity may be affected by buffer composition, pH, and the presence of divalent cations such as Mg²⁺, which is essential for ATP synthase function.
For functional studies, reconstitution into liposomes or nanodiscs may be necessary to preserve the native conformation of this membrane-associated protein.
The F-type ATP synthase complex consists of multiple subunits with distinct functions. Subunit b 2 differs from other subunits in several key aspects:
Unlike the catalytic subunits that bind nucleotides and undergo conformational changes during catalysis, subunit b 2 serves as part of the stator, preventing the F₁ sector from rotating with the central stalk during ATP synthesis.
For investigating interactions between ATP synthase subunit b 2 and other components of the ATP synthase complex, researchers should consider these methodological approaches:
Cross-linking studies coupled with mass spectrometry: This approach can identify interaction interfaces between subunit b 2 and neighboring subunits. Use photo-activatable or chemical cross-linkers followed by digestion and MS/MS analysis to map interaction sites.
Cryo-electron microscopy (Cryo-EM): Recently used successfully to resolve structures of mycobacterial ATP synthases , this technique can capture the entire complex in different conformational states, revealing how subunit b 2 interfaces with other components.
FRET-based assays: By labeling subunit b 2 and potential interaction partners with appropriate fluorophores, researchers can monitor real-time interactions and conformational changes during ATP synthesis/hydrolysis.
Site-directed mutagenesis: Systematic mutation of conserved residues in subunit b 2 followed by functional assays can identify critical interaction residues. This approach has been successfully applied to study regulatory domains like the αCTD in mycobacterial ATP synthases .
Hydrogen-deuterium exchange mass spectrometry (HDX-MS): This technique can map the solvent accessibility of different regions of subunit b 2, providing insights into which domains interact with other subunits and which are exposed to solvent.
When designing these experiments, researchers should consider that interactions may be dynamic and state-dependent, requiring analysis under different physiological conditions.
Assessing the functional integrity of recombinant ATP synthase subunit b 2 after purification presents unique challenges since the subunit itself does not possess enzymatic activity. Researchers should employ these complementary methods:
Circular dichroism (CD) spectroscopy: This technique provides information about secondary structure content, confirming that the recombinant protein is properly folded.
Reconstitution assays: The ultimate test of functionality involves reconstituting the purified subunit b 2 with other ATP synthase components and measuring the ATP synthesis/hydrolysis activity of the reconstituted complex. Decreased activity compared to reconstitution with native subunit b 2 would indicate compromised functionality.
Binding assays with interaction partners: Using techniques such as microscale thermophoresis (MST) or isothermal titration calorimetry (ITC) to quantify binding affinities between subunit b 2 and known interaction partners can provide evidence of functional integrity.
Limited proteolysis: Properly folded proteins often display characteristic resistance patterns to proteolytic digestion. Changes in digestion patterns can indicate structural abnormalities.
Size exclusion chromatography coupled with multi-angle light scattering (SEC-MALS): This can verify that the protein maintains its expected oligomeric state, which is critical for function within the ATP synthase complex.
Unlike analyses of catalytic subunits where direct activity measurements are possible , assessment of structural subunits like b 2 relies more heavily on structural integrity and protein-protein interaction analyses.
To investigate the specific role of ATP synthase subunit b 2 in Maricaulis maris energy metabolism, researchers should consider these experimental approaches:
Gene knockout/knockdown studies: Create atpF2 deletion or conditional expression strains and analyze changes in growth rates, ATP production, and proton gradient maintenance under different metabolic conditions.
Site-directed mutagenesis of conserved residues: Based on structural data or sequence alignments, mutate key residues and analyze effects on ATP synthesis efficiency, similar to studies conducted with mycobacterial ATP synthase components .
In vivo cross-linking followed by immunoprecipitation: This can identify novel interaction partners of subunit b 2 under different metabolic conditions, providing insights into its regulatory roles beyond structural support.
Metabolic flux analysis: Compare metabolic pathway utilization between wild-type and atpF2-mutant strains to understand how alterations in ATP synthase function affect global cellular metabolism.
Membrane potential measurements: Using fluorescent probes, measure how mutations in subunit b 2 affect the ability of Maricaulis maris to maintain membrane potential under different energetic conditions.
Structural studies of the intact ATP synthase complex: Using techniques like cryo-EM (as applied to mycobacterial ATP synthase ), compare the structure of wild-type complexes with those containing mutated subunit b 2 to understand structural consequences.
These approaches collectively would provide a comprehensive understanding of how subunit b 2 contributes to energy metabolism in Maricaulis maris.
ATP synthase inhibitors have become powerful tools for studying bacterial energy metabolism and represent potential antimicrobial agents. Their research implications include:
Selective targeting: Structural differences between bacterial ATP synthases, like the mycobacterium-specific γ-loop and αCTD , provide opportunities for species-specific inhibitors with minimal effects on human ATP synthase, reducing potential toxicity.
Metabolic vulnerability identification: Inhibitor studies have revealed that bacteria like Mycobacterium tuberculosis are particularly vulnerable to ATP depletion when in dormant states, as demonstrated with inhibitors like bedaquiline (BDQ) and GaMF1 that target mycobacterial ATP synthase .
Resistance mechanism elucidation: Research with ATP synthase inhibitors has uncovered novel resistance mechanisms, providing insights into bacterial adaptation and evolution.
Structural biology advancements: The development of inhibitors has driven structural studies of bacterial ATP synthases, including cryo-EM structures of inhibitor-bound complexes , advancing our understanding of the molecular mechanisms of ATP synthesis.
Potential for combination therapies: Understanding how ATP synthase inhibition affects other metabolic pathways has revealed potential synergistic drug combinations targeting energy metabolism.
Studying how inhibitors interact with different subunits, including structural components like subunit b 2, can provide fundamental insights into the coupling mechanism between proton translocation and ATP synthesis.
For optimal expression and purification of recombinant Maricaulis maris ATP synthase subunit b 2, researchers should consider the following methodological approach:
Expression system selection:
E. coli BL21(DE3) or C43(DE3) strains are recommended for membrane protein expression
Consider using a fusion tag (His₆, MBP, or SUMO) to improve solubility and facilitate purification
The expression vector should contain a T7 promoter with tight regulation to control expression levels
Culture conditions optimization:
Perform expression at lower temperatures (16-25°C) to improve proper folding
Induce with lower IPTG concentrations (0.1-0.5 mM) to prevent inclusion body formation
Consider autoinduction media for gentler protein expression
Cell lysis and membrane preparation:
Use gentle lysis methods (French press or sonication with cooling intervals)
Separate membrane fraction by ultracentrifugation (100,000 × g for 1 hour)
Extract membrane proteins using mild detergents (DDM, LMNG, or C₁₂E₈)
Purification strategy:
Initial capture: Immobilized metal affinity chromatography (IMAC)
Intermediate purification: Ion exchange chromatography
Polishing: Size exclusion chromatography
Consider incorporating a tag cleavage step if the tag might interfere with functional studies
Quality control:
Assess purity by SDS-PAGE and Western blotting
Verify identity by mass spectrometry
Analyze secondary structure by circular dichroism spectroscopy
This methodology provides a starting point that should be optimized based on specific research requirements and the intended applications of the purified protein.
Understanding the conformational dynamics of ATP synthase subunit b 2 during the catalytic cycle requires sophisticated biophysical techniques. Based on approaches successfully applied to other ATP synthase components, the following methods are recommended:
Single-molecule FRET (smFRET):
Hydrogen-deuterium exchange mass spectrometry (HDX-MS):
Compare the exchange patterns under different catalytic states
Identify regions with altered solvent accessibility during the catalytic cycle
This provides detailed structural information without requiring protein modification
Time-resolved cryo-EM:
Capture the ATP synthase complex in different catalytic states by rapid freezing
Analyze the conformational changes in subunit b 2 across these states
Recent advances have made this approach feasible for studying transient intermediates
Site-directed spin labeling with EPR spectroscopy:
Introduce spin labels at strategic positions in subunit b 2
Measure changes in mobility and distance between labels during catalysis
Particularly useful for studying membrane-embedded portions of the protein
Molecular dynamics simulations:
Use atomistic simulations to predict conformational changes in response to rotation
Validate computational predictions with experimental measurements
This approach can provide insights difficult to obtain experimentally
These techniques can be complementary, with computational approaches guiding experimental design and experimental results refining computational models.
Investigating species-specific variations in ATP synthase subunit b 2 requires a comparative approach combining bioinformatics, structural biology, and functional analysis:
Comparative sequence analysis:
Perform multiple sequence alignments of subunit b 2 across diverse bacterial species
Identify conserved domains and species-specific insertions/deletions
Use evolutionary trace methods to identify functionally important residues
Create phylogenetic trees to understand evolutionary relationships
Structural comparison:
Generate homology models based on existing ATP synthase structures
Compare these models to identify structural differences
If possible, determine structures of subunit b 2 from multiple species using cryo-EM or X-ray crystallography
Special attention should be paid to regions analogous to the regulatory domains identified in mycobacterial ATP synthases
Domain swapping experiments:
Heterologous expression studies:
Express Maricaulis maris subunit b 2 in different bacterial hosts
Compare functionality to identify host-specific compatibility factors
Assess how species-specific factors affect assembly and function
Functional comparison across species:
Compare ATP synthesis rates, proton conductance, and inhibitor sensitivity
Correlate functional differences with structural variations
Identify adaptations related to specific environmental niches
This multi-faceted approach would provide insights into how evolutionary pressures have shaped ATP synthase structure and function across bacterial species.
The structural features of ATP synthase subunit b 2 present unique opportunities for antimicrobial drug development, particularly for targeting bacteria with species-specific characteristics:
Targeting protein-protein interfaces:
The interface between subunit b 2 and other components of the ATP synthase complex represents a potential site for small molecule inhibitors
Unlike active site inhibitors, interface inhibitors may achieve greater species specificity
Similar approaches targeting mycobacterial-specific interfaces have shown promise
Exploiting species-specific structural elements:
Disrupting assembly rather than function:
Small molecules that interfere with the incorporation of subunit b 2 into the ATP synthase complex could prevent proper assembly
This approach potentially offers greater specificity than inhibiting the conserved catalytic mechanism
Structure-based design considerations:
High-resolution structural data is essential for rational design of inhibitors
Molecular dynamics simulations can identify transiently exposed binding pockets
Fragment-based drug discovery approaches are particularly suited for targeting protein-protein interfaces
Combination approaches:
The development of such inhibitors could provide new therapeutic options against multidrug-resistant bacteria, particularly those where existing ATP synthase inhibitors like bedaquiline show limited efficacy.
Post-translational modifications (PTMs) represent an understudied aspect of ATP synthase regulation that may have significant implications for understanding bacterial energy metabolism:
Potential PTMs affecting subunit b 2:
Phosphorylation: Could alter structural rigidity or interactions with other subunits
Acetylation: Might affect the charge distribution and interaction properties
Oxidative modifications: As seen in mitochondrial ATP synthase α subunit in Alzheimer's disease , oxidative damage could affect function
Lipid modifications: Could influence membrane association
Methodological approaches for PTM identification:
Mass spectrometry-based proteomics with enrichment for specific modifications
Site-directed mutagenesis of potential modification sites to mimic or prevent modifications
In vitro modification assays to assess functional consequences
Regulatory implications:
PTMs could provide a rapid response mechanism to changing environmental conditions
Different from the structural inhibitory mechanisms seen with the αCTD in mycobacteria , PTMs might offer more dynamic and reversible regulation
PTMs might coordinate ATP synthase activity with other metabolic processes
Species-specific considerations:
The pattern of PTMs might differ between species, contributing to adaptation to different environments
The enzymes responsible for these modifications could be species-specific, offering potential drug targets
Technical challenges:
Low abundance of modifications may require sensitive detection methods
Preserving labile modifications during protein purification requires careful protocol optimization
This represents a frontier area in ATP synthase research with potential implications for understanding bacterial adaptation and energy regulation.
When working with recombinant ATP synthase components like subunit b 2, researchers frequently encounter unexpected results. Here's a systematic approach to interpretation and troubleshooting:
| Observation | Possible Causes | Troubleshooting Approaches |
|---|---|---|
| Low expression yield | Toxicity to host cells; improper codon usage; protein instability | Use specialized expression strains; optimize codon usage; lower induction temperature; add stabilizing agents |
| Protein aggregation | Improper folding; hydrophobic interactions; incorrect buffer conditions | Screen different detergents; optimize buffer composition; use fusion partners to enhance solubility |
| Limited functional activity in reconstituted systems | Incomplete complex assembly; missing interacting partners; improper orientation | Verify all components are present; optimize reconstitution protocol; check protein-lipid ratio |
| Inconsistent activity measurements | Sample heterogeneity; buffer incompatibility; inactive population | Implement additional purification steps; standardize assay conditions; verify protein integrity before each assay |
| Unexpected protein-protein interactions | Non-specific binding; artifacts of overexpression; physiologically relevant but previously unknown interactions | Include appropriate controls; validate with multiple techniques; consider biological significance |
When unexpected results occur with ATP synthase subunit b 2, it's particularly important to consider:
The membrane-associated nature of the protein may require specialized handling
Interactions with other subunits may be necessary for stability and proper folding
The native lipid environment may be critical for maintaining physiological conformation
Researchers should systematically document all experimental conditions and variations, as seemingly minor changes can significantly impact results with complex multi-subunit systems like ATP synthase.
Translating in vitro observations about ATP synthase subunit b 2 to in vivo function presents several significant challenges:
Reconstitution limitations:
In vitro systems often lack the complete cellular context
The lipid composition used for reconstitution may not match the native membrane environment
The precise stoichiometry of components may differ from natural systems
Similar challenges have been noted in studies of mycobacterial ATP synthase components
Regulatory network absence:
In vivo, ATP synthase activity is regulated by numerous factors including metabolic state, ion gradients, and regulatory proteins
These complex regulatory networks are difficult to recreate in vitro
Technical considerations:
The energetic parameters (ΔpH, Δψ) in vitro may not match physiological conditions
Mutations that appear to affect function in vitro may be compensated for in vivo
The time scales of in vitro experiments often differ from physiological processes
Validation approaches:
Complement in vitro studies with genetic approaches (gene deletion, complementation)
Use site-directed mutagenesis to test specific hypotheses in both systems
Develop intermediate complexity systems (spheroplasts, inverted membrane vesicles)
Apply in vivo imaging or labeling techniques to track ATP synthase assembly and localization
Interpretation guidelines:
Establish clear correlations between in vitro parameters and in vivo phenotypes
Consider multiple in vivo readouts (growth rates, ATP levels, membrane potential)
Be cautious about extrapolating from single subunit studies to whole complex function
Addressing these challenges requires integrating multiple experimental approaches and developing more sophisticated in vitro systems that better mimic the cellular environment.